SAN DIEGO, C.A. Jan. 30, 2012 – Interactive Biosoftware, developer of Alamut, the world’s original mutation interpretation software, will showcase the upgraded features of the internationally acclaimed software, at the Annual Clinical Genetics Meeting in Charlotte, N.C. from March 28th to March 30th.  

“Our goal is to make it more feasible for researchers to find solutions for the world’s most devastating diseases,” said André Blavier, Founder and CEO of Interactive Biosoftware.

Alamut has been used to make advances in gene research for rare childhood diseases, hereditary colon cancer, cardiomyopathies, among many other conditions. This software is the only all-in-one research tool that helps geneticists and researchers interpret mutations and variations in human genes. Alamut collects the most significant information from a variety of notable databases and performs interpretation in human gene variations.

“Our interpretation software saves time and increases the quality and productivity of research,” said Blavier. 

Alamut has revolutionized the working process for researchers and geneticists.  Before this software was available, researchers had to manually gather information from dozens of databases and websites—an extremely tedious and time consuming process.

“A project that used to take 45 minutes, now takes only five or ten minutes with Alamut,” said Blavier. “Some labs have organizational or commercial constraints with rigorous deadlines; therefore time saving tools are invaluable.”

Alamut enables researchers to access data without in-house bioinformatics. The data is curated and reliable, and feedback shows that it increases users’ confidence in their reports.

"In developing new genetic assays and evaluating the implications of newly identified sequence variations, Alamut helps me work faster and safer to ensure and document quality in assay design and interpretations," said Helge Rootwelt MD, PhD, of Oslo University Hospital in Norway.  

Alamut is the software of choice for leading university medical centers, hospitals, and private human genome laboratories. Interactive Biosoftware has established significant relations in Western Europe, and in the United States, with Harvard University, Columbia University and the Mayo Clinic. Alamut is currently used by over 200 entities in 25 countries on five continents around the world.

About Interactive Biosoftware: Established in April 2007, Interactive Biosoftware (IB) is a software company located in Rouen, France.  IB provides geneticists and researchers with the most sophisticated, easy to use and reliable software. The company is managed by a core of five seasoned professionals and influenced by academics specializing in the medical field. The company engineers and manufactures the world-renowned decision software, Alamut, which aids geneticists and researchers in interpreting mutations and variations in human genes. The software makes appropriate diagnostics, surveillance, and information-sharing between, and across, all tiers of human genome research. IB strives to play an active role in the process of understanding and finding solutions for society’s most devastating diseases. For more information please visit www.interactive-biosoftware.com; or contact us at info@interactive-biosoftware.com; 619-312-4444.

###

Media Contact:
Annie Eddey
annmichele@amebamarketing.com
o: (858) 946-0246
c: (973) 449-0921